Comparison of Clomid and Lezra with Lezra for Ovulation Induction in Clomid Resistant PCOS Case
- Conditions
- Polycystic Ovarian Syndrome
- Interventions
- Drug: Clomiphene Citrate and letrozole
- Registration Number
- NCT06813118
- Lead Sponsor
- HITEC-Institute of Medical Sciences
- Brief Summary
Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.
- Detailed Description
Subfertility is characterized by the inability to achieve conception despite engaging in regular unprotected sexual intercourse for 1-2 years.PCOS exhibits chacteristic traits such as obesity,heightened insulin resistance accompanied by compensatory hyperinsulinemia,oligo/anovulation and subfertility.Clompiphene citrate induces ovarian stimulation.Letrozole ,an aromatase inhibitor emerges as a novel medication with comparable efficacy to CC as a first line treatment for inducing ovulation in cases of anovulation.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 42
- women of 20-40 years with a history of PCOS and resistant to CC
- Premature ovarian insufficiency
- Husband has oligo azoospermia
- Hypothyroidism
- Hyperprolactinemia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description group 1 Clomiphene Citrate and letrozole clomiphene citrate and letrozole combination group 2 Clomiphene Citrate and letrozole letrozole alone
- Primary Outcome Measures
Name Time Method To compare the rate of ovulation 6 months To compare the rate of ovulation between letrozole alone and letrozole and CC
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
HIT Hospital
🇵🇰Rawalpindi, Punjab, Pakistan
HIT Hospital🇵🇰Rawalpindi, Punjab, PakistanRukhsana Shaheen Afzal, MBBS,FCPSContactTahira Jabeen, MBBS,FCPSContact0312 1519011